Press Release Details

View all news

Avenue Therapeutics Files to Become a Public Reporting Company

December 30, 2015

New York, NY – December 30, 2015 – Avenue Therapeutics, Inc. (“Avenue”), a Fortress Biotech, Inc.
(NASDAQ: FBIO) Company, announced that it filed a registration statement on Form 10 with the Securities
and Exchange Commission (“SEC”) under the Securities Exchange Act of 1934, as amended, for the
purpose of becoming a reporting company.

Categories: Press Releases
View all news